Early Success for TED Drug; New Adrenalectomy Tips; Drug coup for weight reduction

VRDN-001, an anti-IGF-1R antibody, was successful in a Phase I/II clinical trial in people with active thyroid eye disease, with participants seeing an average reduction in proptosis of 2.4mm at 6 weeks , announced Viridian Therapeutics.

Dogs living in colder climates and northern parts of the US were more likely to be diagnosed with diabetes. (plus one)

The American Association of Endocrine Surgeons has published new clinical guidelines for adrenalectomy. (JAMA Surgery)

The Endocrine Society commended the signing of the Inflation Reduction Act, which will formally limit out-of-pocket insulin costs for Medicare patients to $35 per month.

A French pharmaceutical exec admitted he lied to the FDA in an attempt to steal the weight-loss drug Mazindol from Novartis. (Endpoints News)

The University of Maryland School of Medicine, Brigham and Women’s Hospital in Boston, and ProMedica share a $13 million grant from the Patient-Centered Outcomes Research Institute to compare fracture prevention interventions in older people with osteoporosis.

Idaho lawmakers have been ordered to pay $321,000 in attorney fees after violating a US court ruling prohibiting unnecessary barriers to transgender people attempting to legally change their gender on their birth certificates. (AP)

A study funded by WW International found that a commercial weight management program helped people lose more weight than a do-it-yourself approach. (JAMA network open)

  • Kristen Monaco is a staff writer focused on endocrinology, psychiatry, and nephrology news. She is based out of the New York office and has been with the company since 2015.

Comments are closed.